Cite
HARVARD Citation
Tanasijevic, A. et al. (2020). Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusions. Leukemia & lymphoma. 61 (12), pp. 2900-2904. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tanasijevic, A. et al. (2020). Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusions. Leukemia & lymphoma. 61 (12), pp. 2900-2904. [Online].